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ABSTRACT
Prenatal smoke exposure (PSE) is a risk factor for nicotine dependence. One susceptibility gene for 
nicotine dependence is Cytochrome P450 (CYP) 2A6, an enzyme responsible for the conversion of 
nicotine to cotinine and nicotine clearance in the liver. Higher activity of the CYP2A6 enzyme is 
associated with nicotine dependence, but no research has addressed the PSE effects on the 
CYP2A6 gene or its mouse homologue Cyp2a5. We hypothesized that PSE affects Cyp2a5 promoter 
methylation, Cyp2a5 mRNA levels, and nicotine metabolism in offspring. We used a smoke- 
exposed pregnant mouse model. RNA, DNA, and microsomal protein were isolated from liver 
tissue of foetal, neonatal, and adult offspring. Enzyme activity, Cyp2a5 mRNA levels, and Cyp2a5 
methylation status of six CpG sites within the promoter region were analysed via HPLC, RT-PCR, 
and bisulphite pyrosequencing. Our data show that PSE induced higher cotinine levels in livers of 
male neonatal and adult offspring compared to controls. PSE-induced cotinine levels in neonates 
correlated with Cyp2a5 mRNA expression and promoter methylation at CpG-7 and CpG+45. PSE 
increased methylation in almost all CpG sites in foetal offspring, and this effect persisted at CpG- 
74 in male neonatal and adult offspring. Our results indicate that male offspring of mothers which 
were exposed to cigarette smoke during pregnancy have a higher hepatic nicotine metabolism, 
which could be regulated by DNA methylation. Given the detected persistence into adulthood, 
extrapolation to the human situation suggests that sons born from smoking mothers could be 
more susceptible to nicotine dependence later in life.
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Introduction
Nicotine is the most prominent and the primary 
psychoactive component in cigarette smoke, which 
is primarily metabolized by the enzyme Cytochrome 
P450 (CYP) 2A6 [1–3]. The encoding gene CYP2A6 
has been identified as a susceptibility gene for nicotine 
dependence [4], and variation in CYP2A6 predicts 
heavier cigarette consumption [5,6] and delayed 
smoking cessation [7], which are both related to nico-
tine dependence [4,8]. Up until today, a number of 
pharmacogenetics studies in humans have shown that 
nicotine dependence relies on alterations in nicotine 
metabolism [9], which in turn has been associated 
with higher CYP2A6 enzyme activity [10,11].
Cyp2a5, the mouse homologue of CYP2A6, plays 
a prominent role in the clearance of nicotine in the 
liver, as CYP2A5 protein converts 80% of nicotine to 
cotinine [12,13]. This conversion requires the pro-
duction of nicotine- Δ1ʹ(5ʹ)-iminium ion first, which 
is then subsequently converted to cotinine by alde-
hyde oxidase [12]. Similar to CYP2A6, Cyp2a5 is 
primarily expressed in the liver [14].
Until now, many studies have described the 
adverse effects of smoking during pregnancy on foetal 
development [15], metabolic disease [16,17], smoking 
behaviour [18,19] and the risk to develop the smok-
ing-related diseases such as chronic obstructive pul-
monary disease (COPD) [20]. These observations are 
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supported by experimental mouse studies from our 
own group [15,21,22] and others [23–25].
Despite the above-mentioned plethora of stu-
dies, relatively little is known about the underlying 
mechanisms that contribute to the impact of pre-
natal smoke exposure (PSE) on smoking behaviour 
and nicotine dependence. However, following the 
prenatal programming paradigm regarding prena-
tal epigenetic changes such as alterations in DNA 
methylation patterns and their role in onset of 
diseases, it is suggested that changes in DNA 
methylation could be one of the contributing 
mechanisms in dependency establishment. Thus 
far, a number of birth cohort studies indeed 
reported aberrantly methylated CpG sites in per-
ipheral blood [26], placenta [27] and buccal cells 
[28] from children of smoking mothers. 
Furthermore, in the mouse studies from our 
group, PSE was shown to induce differential gene 
regulation and DNA methylation profiles of 
a variety of genes [29,30], but this effect was not 
shown by other studies [31].
However, to our knowledge, nothing has been 
reported on the effect of PSE on nicotine metabo-
lism and possible nicotine dependence. Therefore, 
we investigated the effect of PSE on hepatic 
Cyp2a5 gene expression, promoter methylation, 
and enzyme activity in male and female offspring 
from smoke exposed pregnant mice. To establish 
persistence of the PSE effect, this was investigated 
across three developmental stages, namely foetal 
(E17.5), neonatal (D3), and adult (D140).
Results
Higher Cyp2a5 mRNA expression and promoter 
methylation in male PSE offspring
PSE increased Cyp2a5 mRNA levels in the liver of 
neonates (p = 0.029, Figure 1(c)), which was most 
prominent in male offspring (p = 0.015, Figure 1 
(d)). PSE had no effect on Cyp2a5 mRNA steady 
state in foetal (Figure 1(a,b)) and adult livers of 
both sexes (Figure 1(e,f)). Interestingly, when 
comparing control male and female adult groups, 
females had a higher Cyp2a5 mRNA content than 
male adult offspring (p < 0.0001, Figure 1(f)).
To investigate whether the observed PSE- 
induced mRNA levels were associated with 
Cyp2a5 promoter methylation, the percentage of 
methylation of six CpG sites (CpG-614, CpG-589, 
CpG-542, CpG-74, CpG-7, and CpG+45) was 
measured using bisulphite pyrosequencing.
In foetal livers, PSE-induced Cyp2a5 hypermethy-
lation, both in male and female offspring at CpG-614 
(male: p = 0.0009, fold-change = 1.06, female: 
p = 0.001, fold-change = 1.05; Figure 2(a)), CpG-589 
(male: p = 0.0005, fold-change = 1.06, female: 
p = 0.003, fold-change = 1.08; Figure 2(a)), and 
CpG-542 (male: p = 0.001, fold-change = 1.1, female: 
p = 0.004, fold-change = 1.1; Figure 2(a)). PSE- 
induced hypermethylation was found in male foetuses 
at CpG-74 (p = 0.01, fold-change = 1.1, Figure 2(a)), 
but not in females. In contrast, in females, PSE- 
induced hypermethylation at CpG-7 (p = 0.04, fold- 
change = 1.12, Figure 2(a)) and CpG+45 (p = 0.05, 
fold-change = 1.17, Figure 2(a)). In neonatal livers, 
PSE-induced Cyp2a5 hypermethylation was detected 
in both male and female mice at CpG-74 (male: 
p = 0.01, fold-change = 1.1, female: p = 0.03, fold- 
change = 1.07; Figure 2(b)). In male neonates, PSE- 
induced hypermethylation was found at CpG-614 
(p = 0.05, fold-change = 1.03, Figure 2(b)) and CpG- 
542 (p = 0.04, fold-change = 1.05, Figure 2(b)). In 
females, PSE-induced hypermethylation was found 
at CpG+45 (p = 0.04, fold-change = 1.17, Figure 2 
(b)). All other analysed CpG sites of the Cyp2a5 pro-
moter were not found to be influenced by PSE (Figure 
2(b)). In adult livers, higher methylation of CpG-74 
was detected in PSE male offspring (p = 0.03, fold- 
change = 1.21, Figure 2(c)), while no PSE effect was 
observed in all other analysed CpG sites, both in male 
and female offspring (Figure 2(c)). In addition, we 
investigated whether these differentially methylated 
CpG sites were mediated by DNA methyltransferase 
(DNMT) enzymes. Dnmt1 expression was lower in 
PSE male foetal offspring, compared to the control 
group (Supplementary Figure 4(a,b)), while no differ-
ences were detected in the neonates and adult off-
spring (Supplementary Figure 4(c-f)). Expression of 
Dnmt3a mRNA and Dnmt3b mRNA was not affected 
by PSE (Supplementary Figures 5(a-f) and Figure 
6(a-f)).
Linking Cyp2a5 mRNA levels with methylation 
across three time points, in PSE male neonates, 
Cyp2a5 mRNA content was positively correlated 
with methylation at CpG+45 site (r = 0.77, 
p = 0.009), as shown in Table 2 and Supplementary 
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Figure 1(c). This correlation was not seen when PSE 
and control male neonates were taken together 
(Table 2, Supplementary Figure 1(a)), or within male 
neonate controls only (Table 2, Supplementary Figure 
1(b)). For CpG-614, methylation in all male neonatal 
livers correlated positively with Cyp2a5 mRNA 
expression (r = 0.48, p = 0.027, Table 2), while no 
correlations were found in PSE female neonates. In 
PSE adult offspring, methylation levels of CpG-614 
were positively correlated with Cyp2a5 expression 
(r = 0.83, p = 0.003, Table 2), while no correlations 
were observed in combined and control adult off-
spring. Furthermore, negative correlations were 
observed for CpG-74 (r = −0.81, p = 0.004, Table 2) 
and CpG-7 (r = −0.84, p = 0.004 Table 2) in PSE adult 
offspring, while no additional correlations were 
detected in both adult offspring groups. In foetuses, 
positive correlations were found at CpG-614 (r = 0.65, 
p = 0.029, Table 2) and CpG-542 in control female 
foetal livers (r = 0.7, p = 0.016, Table 2) while no 
correlation was found in PSE foetal livers.
Our next question addresses the potential persis-
tence of DNA methylation levels across three devel-
opmental stages, foetal, neonatal, and adult. As 
shown in Figure 3, all of CpG sites showed 
a variable pattern at the three different stages 
(p-values<0.0001, Figure 3). For CpG-614, CpG- 
589 and CpG-542 sites, basal levels of DNA methyla-
tion increased from foetal to adulthood 
(p-values<0.0001, Figure 3(a-c)) in both sexes, 
while it was not affected by PSE (Figure 3(a-c)). In 
Figure 1. Cyp2a5 expression in liver of PSE and control in E17.5, 
D3 mice and adult offspring.
Cyp2a5 mRNA expression in whole liver of foetal offspring 
(E17.5, a and b), neonatal offspring (D3, c and d) and adult 
offspring (e and f) in PSE (closed symbols) and control groups 
(open symbols). Data are shown as individual values. If not 
stated otherwise, the comparison of shown groups was not 
significant. (Mann–Whitney U-test). *p ≤ 0.05, *** p ≤ 0.001 
(Mann–Whitney U-test). Circle (○) symbol(s) = male, square (□) 
symbol(s) = female. 
Figure 2. Sex-dependent Cyp2a5 promoter methylation across 
three time points (E17.5, D3 mice and adult offspring). DNA was 
isolated from whole liver of foetuses (E17.5, a), neonatal off-
spring (D3, b) and adult offspring (c) in PSE (closed symbols) 
and control groups (open symbols). DNA was subjected to 
bisulphite sequencing-based methylation analysis of the 
Cyp2a5 promoter region and the percentage of DNA methyla-
tion was assessed. Data of the 6 targeted CpG-sites are pre-
sented per sex and exposure as individual values with median 
as a horizontal line. CpG-site annotations are relative to the ATG 
start codon. If not stated otherwise, the comparison of shown 
groups was not significant. *p ≤ 0.05, ** p ≤ 0.01, ***p ≤ 0.001 
(Mann-Whitney U-test). Circle (○) symbol(s) = male, square (□) 
symbol(s) = female.
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Table 1. Sequences of primers used in bisulphite-based methylation analysis.
Gene Targeted CpG-sites Sequence 5ʹ-3’
Cyp2a5 CpG-614 to −542 For: TTTGTGTTTGTTTTGAGTGTTGGGATTA 
Rev: CCCCATCCACAACCATTCTT 
Seq: GTTGGGATTATAGGTTTATATTA 
Sequence to analyse: 
TTATATTYGATTTTTGGGAGTTTTTTAATGAAGAGGATTTTGAATTTAAGGATGYGAGAA GTGGAGATTT TAGGGTTATYGG




Sequence to analyse: 
S1: GATTAAAGTTYGTTTTTTTGTTTTTGGATGTATAAAAGTAAGTTAATT 
S2: TTATYGTTATTATGTTGATTTTAGGATTTTTTTTGGTGGTTGTAGTGGTTTTTTTTAGYGTTTTGGTTTT
Table 2. Correlations between Cyp2a5 mRNA expression and promoter methylation in foetal (E17.5), neonatal (D3) and adult 
offspring liver.
E17.5



















CpG-614 r -0.02 -0.23 0.17 0.17 -0.29 -0.23 -0.45 0.65 -0.13
p-value ns ns ns ns ns ns ns 0,02* ns
CpG-589 r 0.23 0.04 0.38 0.46 0,19 0.32 -0.1 0,57 0.47
p-value ns ns ns ns ns ns ns ns ns
CpG-542 r 0.11 -0.38 0.41 0.26 0.1 -0.56 -0.38 0.70 0.23
p-value ns ns ns ns ns ns ns 0,01* ns
CpG-74 r 0.21 0.19 0.25 0.35 0.05 -0.05 0.13 0.48 0.06
p-value ns ns ns ns ns ns ns ns ns
CpG-7 r 0.02 -0.04 0.01 0.19 -0.12 0.07 -0.15 0.40 -0.14
p-value ns ns ns ns ns ns ns ns ns
CpG+45 r 0.25 0.1 0.38 0.24 0.20 -0.25 0.16 0.44 0.29
p-value ns ns ns ns ns ns ns ns ns
D3



















CpG-614 r 0,29 0.48 0.16 0.26 0.05 0.08 0.13 0.07 0.04
p-value ns 0.02* ns ns ns ns ns ns ns
CpG-589 r 0.28 0.38 0.27 0.21 0.15 0.12 0.31 0.04 0.26
p-value ns ns ns ns ns ns ns ns ns
CpG-542 r 0.24 0.33 0.23 0.48 0.12 0.52 0.33 0.32 0.08
p-value ns ns ns ns ns ns ns ns ns
CpG-74 r 0.35 0.17 0.02 0.37 0.24 -0.19 0.50 -0.39 -0.02
p-value ns ns ns ns ns ns ns ns ns
CpG-7 r 0.12 0.17 0.00 0.03 0.37 0.23 0.51 -0.61 0.47
p-value ns ns ns ns ns ns ns ns ns
CpG+45 r 0.27 0.4 -0.04 0.29 0.23 0.09 0.77 0.11 -0.27
p-value ns ns ns ns ns ns 0,009** ns ns
Adult

















CpG-614 r 0.22 0.12 0.21 0.02 0.83 0.18 0.2 0.15 -0.81
p-value ns ns ns ns 0.003** ns ns ns ns
CpG-589 r 0.24 0.17 0.33 0.38 -0.11 0.24 -0.12 0.29 0.31
p-value ns ns ns ns ns ns ns ns ns
CpG-542 r -0.18 0.1 0.01 -0.36 0.22 0.22 -0.60 0.1 -0.31
p-value ns ns ns ns ns ns ns ns ns
CpG-74 r -0.41 0.43 -0.11 -0.17 -0.82 0.62 0.15 0.41 -0.6
p-value ns ns ns ns 0.004** ns ns ns ns
CpG-7 r -0.42 0.03 -0.47 -0.32 -0.85 0.11 -0.66 -0.64 0.61
p-value ns ns ns ns 0.004** ns ns ns ns
CpG+45 r -0.44 0.12 0.11 -0.57 -0.57 0.1 -0.1 -0.28 0.4
p-value ns ns ns ns ns ns ns ns ns
*p ≤ 0.05, ** p ≤ 0.01, ***p ≤ 0.001. P-values were adjusted by the Bonferroni method. 
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control male and female offspring, methylation pat-
terns of CpG-74 and CpG-7 increased from foetal to 
neonatal stage but reversed to hypomethylated in 
adulthood (p-values<0.0001, Figure 3(d and e)). 
Interestingly, PSE effects were detected for CpG-74 
across three developmental stages in male offspring, 
(p-values<0.05, Figure 3(d)), whereas at CpG-74, the 
PSE effect on methylation disappeared in female 
foetus and adults (Figure 3(d)). For CpG+45, hyper-
methylation was observed at the neonatal stage when 
compared to neonates across foetal to neonatal stage 
(p < 0.01, Figure 3f), which was only observed in 
male offspring of both the control and PSE groups 
(Figure 3(f)). In female controls, methylation at CpG 
+45 remained stable across three time points, while 
PSE increased methylation at both the foetal and 
neonatal stages (p-values<0.05, figure 3f).
Prenatal smoke exposure increased the nicotine 
metabolism in neonatal and adult male offspring
Our final question aimed towards the understand-
ing of whether altered Cyp2a5 mRNA levels, as 
observed in PSE neonatal offspring, was accompa-
nied by an aberrant nicotine metabolism. This 
research question is based on the understanding 
that the enzyme CYP2A5 is responsible for con-
version of nicotine after smoke exposure. 
Conversion of the in vitro nicotine metabolism to 
cotinine was measured by HPLC-L and MS, as 
shown in Figure 4(c and d).
Interestingly, PSE-induced cotinine formation 
to higher levels in livers of male neonates when 
compared to controls (p = 0.058; Figure 4(f)). In 
female neonates, this PSE effect was not seen. This 
PSE-induced cotinine formation was even more 
pronounced in PSE male adult offspring 
(p = 0.03; Figure 4(g)) when compared to the 
male adult controls. In contrast, cotinine forma-
tion was decreased in PSE female offspring, when 
compared to female adult controls (p = 0.03; 
Figure 4(g)).
A comparison of basal levels of cotinine for-
mation in male and female controls showed that 
female neonates and adults had a higher nicotine 
metabolism than their male counter parts (neo-
nates: p = 0.007; adults: p < 0.0001; Figure 4(f and 
g)). In foetuses, the nicotine metabolism was not 
affected by PSE (Figure 4(e)), nor were there 
Figure 3. Time points comparisons of sex-dependent Cyp2a5 pro-
moter methylation status in PSE and control groups. The ANOVA test 
was used to do the comparison analysis among the foetal stage 
(E17.5), neonatal period (D3 means three days after birth) and adult-
hood (D140 means 140 days later after birth). P-values<0.0001 were 
detected by ANOVA test in all of CpG sites over three time points. 
Mann–Whitney U-test was used to test the comparisons between two 
time points in control (open symbols) and PSE (closed symbols) 
groups for 6 promoter methylation CpG sites. Data are represented 
as mean± SEM; CpG-site annotations are relative to the ATG start 
codon. *p ≤ 0.05, *** p ≤ 0.001 (Mann-Whitney U-test). Circle (○) 
symbol(s) = male, square (□) symbol(s) = female.
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differences in control levels of cotinine formation 
in males compared to females.
In foetal livers, the level of cotinine formation 
correlated positively to Cyp2a5 expression when 
data of all foetuses were plotted together 
(r = 0.45, p = 0.003; Supplementary Figure 2 
(a), Table 3). This correlation was mainly driven 
by the control female foetuses (r = 0.78, 
p = 0.01; Supplementary Figure 2(c), Table 3), 
as no correlation was detected in PSE groups. 
Furthermore, a lower correlation was also seen 
in control when male and female foetuses were 
combined (r = 0.57, p = 0.01; Supplementary 
Figure 2(b), Table 3). In male neonates, PSE- 
induced cotinine formation correlated positively 
to Cyp2a5 expression (r = 0.81, p = 0.01; 
Figure 4. Optimization and the cotinine formation levels of in vitro nicotine metabolism in E17.5, D3 mice and adult offspring. 
Cotinine formation of nicotine metabolism of foetuses (E17.5), three-day-old offspring (D3) and adult offspring in PSE and control 
groups. The nicotine metabolism was measured by HPLC-L as described in the material and methods section. The assay was 
optimized with respect to incubation time (a) and cytosolic protein concentration (b). Arrows at the X-axis indicate conditions used 
for actual experiments. C presents the HPLC chromatogram separation of a blank sample containing the standards nicotine and 
cotinine and the cotinine was produced in liver microsomes of PSE male neonatal offspring. D presents the cotinine analysis by 
LCMS. Cotinine, corresponding with m/z 177 was detected both in standard cotinine and in the microsome sample. The levels of 
cotinine formation were measured in foetal (e), three-day-old offspring (f) and adult offspring (g) of both groups. Circle (○) 
symbol(s) = male, square (□) symbol(s) = female. Data are shown as individual values. If not stated otherwise, the difference 
between groups was not significant. *p ≤ 0.05, ** p ≤ 0.01 (Mann-Whitney U-test). Open symbol(s) = control group, closed 
symbol(s) = PSE.
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Supplementary Figure 2(e), Table 3), whereas no 
significant correlation was observed when data 
from all male neonates were combined (r = 0.53, 
p = ns; Supplementary Figure 2(d), Table 3). In 
control adult offspring, the level of the cotinine 
formation positively correlated with Cyp2a5 
expression (r = 0.67, p = 0.002; Figure 2(g), 
Table 3), while no correlation was detected 
when data from PSE and control mice were 
combined, as shown in Supplementary figure 
2(f).
Levels of DNA methylation versus levels of 
cotinine formation shows that, in all cases, strong 
correlations were found in both male PSE neonatal 
and adult mice. In PSE neonatal males, levels of 
cotinine formation correlated strongly with CpG 
Table 3. Correlations between cotinine levels, Cyp2a5 mRNA expression and promoter methylation in foetal (E17.5), neonatal (D3) 
and adult offspring liver.
E17.5
correlation of / with


















Cyp2a5 (2-dCT) r 0.45 0.47 0.41 0.57 0.33 0.41 0.46 0.78 0.20
p-value 0.00** 0.03* ns 0.01** ns ns ns 0.01** ns
Cyp2a5 promoter 
methylation [%]
CpG-614 r -0.15 -0,21 -0.14 0.30 -0.07 -0.41 0.19 0.44 -0.27
p-value ns ns ns ns ns ns ns ns ns
CpG-589 r -0.59 0.01 -0.10 0.30 -0.05 0.07 0.28 0.65 -0.35
p-value ns ns ns ns ns ns ns ns ns
CpG-542 r 0.15 0.17 0.03 0.36 -0.09 0.55 -0.18 0.87 -0.17
p-value ns ns ns ns ns ns ns 0.00*** ns
CpG-74 r 0.21 0.31 0.10 0.12 0.26 0.36 0.30 -0.03 0.06
p-value ns ns ns ns ns ns ns ns ns
CpG-7 r 0.14 0.26 0.01 0.54 -0.19 0.42 0.08 0.75 -0.38
p-value ns ns ns 0.02* ns ns ns ns ns
CpG+45 r 0.31 0.34 0.28 0.4 0.37 0.19 0.57 0.57 0.21
p-value ns ns ns ns ns ns ns ns ns
D3
correlation of / with
Cotinine formation (nmol/min/ 















Cyp2a5 (2-dCT) r 0.16 0.53 -0.12 0.01 0.21 0.21 0.81 0.14 -0,18
p-value ns ns ns ns ns ns 0.01** ns ns
Cyp2a5 promoter 
methylation [%]
CpG-614 r -0.10 0,46 -0.63 0.14 -0.30 0.59 0.21 -0.43 -0.79
p-value ns ns 0.00*** ns ns ns ns ns 0.01**
CpG-589 r -0.14 0.48 -0.63 0.01 -0.28 0.69 0.20 -0.61 -0.59
p-value ns ns 0.00*** ns ns ns ns ns ns
CpG-542 r -0.26 -0.38 -0.42 -0.18 -0.26 0.20 -0.28 -0.54 -0.17
p-value ns ns ns ns ns ns ns ns ns
CpG-74 r -0.29 -0.01 -0.29 -0.57 -0.12 -0.03 -0.28 -0.36 0.18
p-value ns ns ns ns ns ns ns ns ns
CpG-7 r 0,47 0,70 0.30 0.38 0.29 0.46 0.83 0.32 0.18
p-value ns 0.00*** ns ns ns ns 0.00*** ns ns
CpG+45 r 0.19 0,77 -0.52 0.12 0.21 0.80 0.86 -0.64 -0.44
p-value ns 0.00*** ns ns ns ns 0.00*** ns ns
Adult
correlation of / with
















Cyp2a5 (2-dCT) r 0.23 0.26 0.21 0.67 -0.67 0.21 -0.37 0.47 -0.41
p-value ns ns ns 0.00** ns ns ns ns ns
Cyp2a5 promoter 
methylation [%]
CpG-614 r -0.24 -0.42 -0.12 0.02 -0.75 -0.50 0.30 0.42 -0.89
p-value ns ns ns ns 0.01** ns ns ns ns
CpG-589 r 0.04 0.05 -0.09 0.24 -0.35 -0.15 -0.78 0.07 -0.53
p-value ns ns ns ns ns ns ns ns ns
CpG-542 r -0.37 -0.37 -0.21 -0.33 -0.51 -0.16 0.00 0.28 -0.90
p-value ns ns ns ns ns ns ns ns ns
CpG-74 r -0.19 -0.18 0.64 -0.28 0.73 -0.17 -0.52 0.48 0.90
p-value ns ns 0.01** ns 0.01** ns ns ns ns
CpG-7 r 0.017 0.21 0.01 -0.17 0.55 0.19 -0.41 -0.22 0.89
p-value ns ns ns ns ns ns ns ns ns
CpG+45 r -0.03 0.23 0.21 -0.15 0.31 0.65 -0.20 0.03 0.80
p-value ns ns ns ns ns ns ns ns ns
*p ≤ 0.05, ** p ≤ 0.01, ***p ≤ 0.001. P-values were adjusted by the Bonferroni method. 
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+45 and CpG-7 methylation (r = 0.86, p = 0.008 
and r = 0.83, p ≤ 0.01; Table 3), whereas it strongly 
negatively correlated with CpG-614 methylation in 
PSE female neonates (r = −0.79, p = 0.01; Table 3). 
In contrast, methylation of CpG-7 (r = 0.70, 
p ≤ 0.01; Table 3) and CpG+45 (r = 0.77, 
p ≤ 0.001; Table 3) correlated with cotinine levels 
in all male neonatal groups, while CpG-614 
(r = −0.63, p = 0.009; Table 3) and CpG-589 
(r = −0.63, p = 0.009, Table 3) negatively corre-
lated with cotinine levels in all female neonates. In 
adult offspring, a majority of correlations of coti-
nine formation levels with DNA methylation levels 
were detected in PSE adult offspring. Promoter 
methylation at CpG-614 was negatively correlated 
with cotinine levels in PSE adult offspring 
(r = −75, p = 0.01, Table 3). In contrast, for 
CpG-74, promoter methylation correlated posi-
tively with cotinine levels (r = −0.75, p = 0.01, 
Table 3), while no other correlations were 
observed in PSE adult offspring (Table 3).
Comparison of gene expression, methylation 
profiles and cotinine formation of nicotine 
metabolism
Comparisons of the Cyp2a5 mRNA expression, 
promoter methylation levels, and the nicotine 
metabolism across three time points in control 
offspring show that mRNA levels of Cyp2a5 and 
the level of cotinine formation were much higher 
in adult offspring, when compared to foetal and 
neonatal offspring, in both sexes (p-values<0.0001, 
Supplementary Figure 3(a) and (b)). In addition, 
basal levels of cotinine formation were higher in 
female neonates (p = 0.0002; Supplementary 
Figure 3(b)), when compared to female foetuses. 
This was accompanied with higher methylation 
levels of all measured CpG sites in both sexes, 
except for CpG+45 (p-values≤0.01; 
Supplementary Figure 3(c,d)). In adult offspring, 
hypermethylation was detected at three CpG sites 
(p-values<0.0001; CpG-614, CpG-589, and CpG- 
542), compared to foetuses and neonates 
(Supplementary Figure 3(c)). Inversely, promoter 
methylation was lower at two CpG sites 
(p-values≤0.0001; CpG-74 and CpG-7) in adult 
offspring, for both sexes, compared to foetuses 
and neonates, as shown in Supplementary Figure 
3(c,d).
Discussion
In this study, we found that PSE increased the 
nicotine metabolism in male neonatal and adult 
but not in foetal offspring. This observation corre-
lated with higher Cyp2a5 mRNA levels along with 
elevated promoter methylation in neonates but not 
in adults. In addition, while the PSE-induced nico-
tine metabolism increased from the foetal devel-
opmental stage to adulthood, partial to almost 
complete waning of the PSE-induced Cyp2a5 pro-
moter methylation was observed over time, which 
was sex dependent. Finally, female neonates and 
adult mice had a higher hepatic nicotine metabo-
lism than their male counterparts, and PSE had 
a downregulatory effect on nicotine metabolism in 
female adults.
Our observation that PSE increased the nicotine 
metabolism in neonatal and adult offspring could 
be relevant with respect to human smoking beha-
viour, as a higher nicotine metabolism is generally 
associated with heavier smoking, higher depen-
dency to nicotine, and more difficulty to quit 
cigarette smoking [32,33]. Indeed, Kandel et al. 
reported aberrant smoking behaviour in children 
born to smoking mothers, in which PSE daughters 
had a higher risk to start smoking, and the smok-
ing behaviour was more persistent than in sons in 
adolescence age [19]. Whether the sex-difference 
in smoking behaviour of PSE adolescence is based 
on epigenetically regulation of genes is worth to 
further investigate in human subjects.
In our mouse study, the PSE effect on nicotine 
metabolism was also sex-dependent since the effect 
was only seen in male offspring. This is of interest 
as in a study by Klein et al. in preadolescent mice, 
prenatal nicotine exposure induced the preference 
for drinking nicotine-containing water, an effect 
that was only seen in males, while female mice 
appeared to be unresponsive to treatment [25]. In 
addition, in a study where pregnant rats were 
treated with nicotine, only male hyperactive off-
spring exhibited a significant increase in the cor-
tical receptor densities whereas the hyperactive 
females did not. Evidence suggests that only male 
offspring of nicotine-exposed dams are also 
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susceptible to neurochemical effects of intrauterine 
nicotine exposure [34].
In the current study, for the CpG sites that were 
affected by PSE, methylation levels were increased, 
which was seen at three time points in both sexes. 
Promoter methylation is usually associated with 
repressed gene expression, but recent findings 
[17,22] suggest that this association could also 
occur inversely, which is in line with our previous 
studies [29,30] and studies by others [35]. 
Interestingly, in three development stages, PSE 
caused a persistent increase of methylation at 
CpG-74 when compared to control groups. This 
confirms human studies [26,36] showing that PSE- 
induced differentially methylated CpG sites in 
MYO1 G and CNTNAP2 were persistent at birth, 
during childhood and during adolescence in the 
replication cohort. Indeed, the causal link between 
DNA (de)methylation and gene expression and 
even further protein activation is complex, given 
that DNA methylation is only one of the known 
epigenetic modifications. Other modes include 
histone modifications, chromatin remodelling, 
and RNA-based mechanisms (lncRNAs/miRs). 
All of these modes seem to be interlinked, but 
their chronological order and the exact 
mechanism(s) that may connect these modes still 
need to be described to their full extent.
In this study, the PSE effect was the most strik-
ing in male neonates. PSE-induced Cyp2a5 mRNA 
expression was correlated with both CpG+45 
methylation as well as with elevated cotinine levels. 
As this effect was not seen in females, it indicates 
that this CpG site may play a regulatory role in 
sex-dependent regulation of Cyp2a5 expression. 
Studies have reported sex-dependent methylation 
patterns of CpG sites in the livers of male and 
female mice [37,38]. It is known that sex hor-
mones can play a major role in regulating sex- 
dependent DNA methylation, as described in the 
mouse model by Takasugi et al. [39]. In that study, 
male mice, treated with female-like growth hor-
mone showed differential methylation of CpG sites 
of Cyp17a1, Cxcl11, and Nmt in the liver when 
compared to non-treated male mice, and this 
observation was also described in other organs 
[40]. In addition, Koudsi et al. demonstrated 
DNA methylation changes in regulating CYP2A6 
expression in a pilot study of human livers. In that 
study, no prominent role for DNA methylation 
changes was observed with respect to the regula-
tion of CYP2A6 gene expression in human livers 
[41]. Based on this finding, a lack of association 
between DNA methylation and CYP2A6 expres-
sion suggests that other gene areas, such as the 
proximal promotor CpG sites (1000–100 bp) in 
relation to the gene’s transcription start site 
might be relevant in regulating CYP2A6 expres-
sion, which needs to be investigated further. 
Moreover, in murine hepatocytes, two major 
regions of Cyp2a5 regulation were observed in 
the promoter, which are the distal (AHR and 
USF-1 within 2700–1500bp) and the proximal 
region (HNF, NF-1and C/EBP within 1000– 
10bp), as described by Arpiainen et al. [42]. 
Therefore, Arpianen and colleagues compared the 
distal promoter region with the proximal promo-
ter region in the transcriptional regulation of 
Cyp2a5 expression, showing HNF, NF-1and C/ 
EBP transcription factors within the proximal 
region are the key activators of the Cyp2a5 expres-
sion, when compared to the distal region.
Next to this, we assessed mRNA expression of 
the DNA methyltransferases across three develop-
ments stages. There are two different DNA methy-
lation processes: maintenance (DNMT1) and de 
novo (DNMT3a and DNMT3b). Interestingly, 
lower Dnmt1 levels were observed in male foetuses 
only, supporting a study in which it has been 
shown that Dnmt1 enzyme can be reduced by 
current cigarette smoke exposure, which downre-
gulated target genes in in vitro and ex vivo studies 
[43,44]. This result could be considered as the 
‘current smoke’ exposure effect, which was present 
in the foetuses. As neonatal and adult offspring 
have not been exposed after they were born, this 
current smoke effect would not apply to these 
groups.
In our study, we observed that nicotine meta-
bolism increased over time, as adult mice had 
a higher cotinine formation than neonates and 
foetuses. In addition, the PSE effect on nicotine 
metabolism was also observed in neonatal and 
adult offspring but not in foetal offspring. This 
result suggests that offspring in the foetal stage 
had a very low nicotine metabolism, which was 
not induced by PSE. Indeed, in a human study by 
Dempsey et al., it was reported that the half-life of 
1378 K. LKHAGVADORJ ET AL.
nicotine in serum is three to four times longer in 
newborns than in adults [45], indicating that foetal 
and newborn liver might have lesser nicotine 
clearance than adult [46]. In addition, during 
pregnancy, the metabolic clearance of nicotine is 
relatively high [47], resulting in foetal nicotine 
clearance being primarily controlled by the 
mother’s hepatic blood flow.
With respect to Cyp2a5 methylation, this is the 
first study to report on methylation of Cyp2a5 
over time and after PSE. We found a decline in 
the number of differentially methylated CpG sites 
over time after PSE, suggesting that PSE-induced 
Cyp2a5 methylation is reversible over time. One 
explanation could be a diverse cellular composi-
tion in all three developmental stages, which is 
a limitation of this study and which was also as 
reported in previous studies [30,48]. Indeed, in the 
human study, a similar result was described by 
Richmond and colleagues when comparing PSE 
newborns to adolescent offspring [26]. They 
found that differentially methylated CpG sites in 
PSE newborns have been identified in AHRR, 
MYO1 G, GFI1, CNTNAP2, KLF13, CYP1A1 and 
ATP9A genes, which are known as smoke-related 
genes. In that study, CpG sites in less than half of 
the smoking-related genes showed reversibility of 
the methylation pattern in PSE adolescents when 
compared to PSE newborns.
With respect to the functionality of the Cyp2a5 
gene in foetal mice, no PSE effect was seen on 
nicotine metabolism, although methylation was 
higher in four out of six CpG sites, both in male 
and female PSE groups. The potential of PSE to 
induce foetal programming has been addressed in 
multiple studies, but a differential effect in males 
and females has only occasionally been evaluated 
by our research group [29,30] and others [49,50]. 
The present study shows that PSE-induced methy-
lation was observed mostly in foetuses. This result 
could be due to the ‘current’ smoke effect, as 
foetuses were exposed to smoke until they were 
terminated. From the literature, it is known that 
current smoking has a profound effect on DNA 
methylation which for a number of genes disap-
pears after smoking cessation [e.g., ref [51].]. 
Similar effects have been described by us for Igf1 
and Igf1 r methylation in the same pups [30]. This 
‘current’ smoke exposure effect is not present in 
the neonates and adults which have not been 
exposed to smoke after they were born. However, 
neonates may have been exposed to nicotine via 
the mothers’ milk as nicotine could have been 
ingested, when mothers cleaned their fur. The 
waning of the PSE effect over time could therefore 
also be explained by the ‘current’ nicotine expo-
sure at the foetal and neonatal stages and the 
absence of ‘current’ nicotine exposure in adults.
We found that female neonates and female 
adults had a higher nicotine metabolism, which 
supports previous studies in humans [52,53], and 
which suggests that the nicotine and cotinine 
clearance is higher in women than in men. 
Indeed, other CYP enzymes may have a role in 
nicotine metabolism [13], and may explain the 
differences seen between males and females. For 
instance, Z. Liu et al. tested the ability of CYP2B6 
to metabolize nicotine in the CYP2B6-humanized 
mouse model [54] showing that the nicotine- 
induced cotinine formation was increased in 
males when compared to females. In contrast, 
a clinical study showed that livers from female 
donors had a higher level of CYP2B6 mRNA, 
protein, and enzyme activity compared to male 
donors [55]. Moreover, CYP2B6 expression is 
known to be stimulated by oestrogen hormones 
[56]. However, as the CYP2B6 is a considerably 
lower activity enzyme in nicotine metabolism 
when compared to the CYP2A6 enzyme [13], we 
do not consider a major role for this enzyme in 
our model. Unfortunately, the molecular mechan-
ism that underlies different CYP2B6 regulation in 
the mouse is not clear. In addition, in humans, the 
inherent gender difference in smoking initiation 
and nicotine addiction was well documented in 
the epidemiological studies [57,58], showing that 
women have greater vulnerability for heritability 
of smoking initiation/persistence compared to 
males (women 66% vs. man 49%) [59].
The nicotine metabolism is also higher in pregnant 
women than in non-pregnant women [47,60], sug-
gesting a dose-dependent effect of the sex hormones 
oestrogen and progesterone on CYP2A6 regulation. 
Indeed, Higashi et al. showed that CYP2A6 mRNA 
was induced by oestradiol in human hepatocytes after 
specific binding of the oestrogen receptor to the puta-
tive oestrogen response element (ERE) on the 
CYP2A6 gene [61]. The sex hormone may also have 
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a direct effect on the nicotine metabolism in rodents. 
In a rat experiment, ovariectomized animals showed 
a lower behaviour motivation effect of nicotine intake 
than controls [62]. Moreover, in another study, higher 
plasma nicotine levels were measured in intact female 
rats compared to male rats, and the sex difference was 
attenuated in ovariectomized animals [63]. Although 
we expected otherwise, a lower nicotine metabolism 
was observed in PSE female adult offspring, compared 
to controls. This might have resulted from PSE- 
induced ovarian steroidogenesis [64,65]. Indeed, stu-
dies in rats have demonstrated that in utero exposure 
to cigarette smoke can result in decreased oestrogen 
hormone [66] in female offspring, explaining 
a different effect of PSE in females.
There were limitations to the study. Throughout 
three development stages, the cellular compositions 
within different liver zones may be a confounding 
factor. Therefore, it would be interesting to assess 
DNA methylation patterns and nicotine metabolism 
in different cell compounds within a specific liver 
zone in future studies. In addition, foetal and neo-
natal offspring only provided us with limited mate-
rial to do all analyses within one mouse. For the 
in vitro nicotine metabolism experiment, firstly, we 
optimized the required ratio of enzymes on higher 
metabolic active specimens. Selected optimized 
ratios were used in the actual in vitro nicotine meta-
bolism experiment.
Conclusion: In this study, we have shown for the 
first time that male neonatal and adult offspring 
from mothers that smoked during pregnancy have 
a higher nicotine metabolism. In neonates, this was 
accompanied by a higher Cyp2a5 gene expression, 
which was correlated with higher DNA methylation. 
As studies have shown a positive relation between 
higher nicotine metabolism and increased nicotine 
dependency, this could imply that in human sub-
jects, male offspring from smoking mothers have 
a higher chance of developing tobacco addiction 
when they start smoking.
Materials and methods
Animals & smoke exposure
C57BL/6 J mice (48 females and 48 males) were 
obtained from Harlan (Horst, The Netherlands) at 
6 weeks of age and housed under standard condi-
tions, with food and water provided ad libitum 
and at a 12-h light/dark cycle. The experimental 
setup was approved by the local committee on 
animal experimentation (DEC6589 B & C; 
University of Groningen, Groningen, The 
Netherlands) and governmental and international 
guidelines on animal experimentation.
Mainstream cigarette smoke was generated by 
a Teague10 smoking machine (Tobacco and 
Health Research Institute of the University of 
Kentucky, Lexington, KY, USA). Over a period of 
7 days, 20 randomly selected primiparous female 
mice were adjusted to cigarette smoke by stepwise 
increasing the number of smoked cigarettes (3R4 
cigarettes; 2.45 mg nicotine/cigarette) from two to 
five per smoking session. On adjustment day 5, 
after the end of the smoking session, all female 
mice were injected with pregnant mare’s serum 
gonadotropin (PMSG, 1.25 i.u.) to stimulate ovu-
lation, and on day 7 with human chorionic gona-
dotropin (hCG, 1.25 i.u.) to induce ovulation. 
Subsequently, female mice were housed overnight 
at a 1:1 mating ratio with males. Mating was con-
firmed by the presence of a vaginal plug the fol-
lowing morning.
Throughout gestation, female mice were housed 
in groups and exposed to air or whole-body smok-
ing sessions twice a day, 7 days per week. After 
delivery, dams and their offspring were no longer 
exposed to cigarette smoke. Dams were separately 
housed, with their offspring.
A total of 48 foetuses (24 males and 24 females) 
from 5 smoke-exposed dams and 4 control dams 
were collected at embryonic stage 17.5 (E17.5) and 
dams were euthanized under anaesthesia. A total 
of 42 pups at postnatal day 3 (D3) were randomly 
selected from prenatally smoke exposed (11 male, 
8 female) and control (11 male, 12 female) groups 
for collection of the liver. Another 34 pups were 
randomly selected from 20 smoke-exposed (6 
male, 6 female) and 19 control (10 male, 12 
female) mice that were exposed to air in the 
Teague10 from 8 weeks of age for the following 
12 weeks (adulthood) until euthanized for collec-
tion of the liver. The livers were immediately fro-
zen in liquid nitrogen and stored at −80°C until 
further use.
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Genetic determination of mouse sex
DNA from the tail of E17.5, D3 and adult mice was 
obtained by SDS denaturation, high salt extraction, 
and precipitation. DNA was amplified as described 
by Lambert et al. [67], using two primer sets which 
are specific for the genes Sry (forward: 5ʹ-TGGTCCC 
GTGGTGAGAGGC-’3, reverse: 5ʹ-TATGTGATG 
GCATGTGGGTTCC-’3) and IL3 (forward: 5ʹ- 
GGGACTCCAAGCTTCAATCA-’3, reverse: 5ʹ- 
TGGAGGAGGAAGAAAA GCAA-’3).
Isolation of DNA and RNA
DNA and RNA were isolated using the All Prep 
DNA/RNA Mini Kit (Qiagen, Cat No. 80,204), 
according to the manufacturer’s protocol.
mRNA expression and Pyrosequencing-based 
bisulphite PCR analysis
Gene expression analysis in whole liver mRNA 
isolates was done via qPCR using qPCR 
MasterMix Plus (Eurogentec, Seraing, Belgium) 
with commercially available primers for Cyp2a4/5 
(Mm00487248_m1, TaqMan® Gene Expression 
Assay, Applied Biosystems, Foster City, CA, 
USA). Primers and probes for Dnmt1, Dnmt3a 
and Dnmt3b were obtained from Invitrogen 
(Breda, The Netherlands), which are described in 
details elsewhere [68]. Detection of amplification 
reactions was performed using the LightCycler® 
480 System (Roche Diagnostics GmbH, 
Mannheim, Germany) with cycling conditions as 
follows: for 2 min at 50°C, for 10 min at 90°C, for 
15 s at 40 cycles of 95°C and for 1 min at 60° 
C. Reactions were performed in triplicate for each 
sample with Gapdh (Mm99999915_m1, TaqMan® 
Gene Expression Assay, Applied Biosystems, 
Foster City, CA, USA) as a reference gene.
DNA in liver tissue of foetal, neonatal, and adult 
mice was isolated and prepared for bisulphite- 
based methylation analysis. For the assessment of 
promoter methylation levels of Cyp2a5, bisulphite 
sequencing primers were designed using 
PyroMark assay design software (version 2.0, 
Qiagen). Selection of CpG-sites was based on 
manual identification of CpG-dinucleotides, using 
ENSEMBL genome web browser (Ensembl 83: 
Dec 2015) and transcript location for the identifi-
cation of gene promoter regions. Extracted geno-
mic DNA was converted with sodium bisulphite 
(EZ DNA methylation Direct™, Zymo Research, 
Irvine, CA), following the manufacturer’s instruc-
tions. In short, the bisulphite conversion was car-
ried out in the dark at 98°C for 10 minutes and 64° 
C for 3.5 hours, followed by desulphonation of the 
converted DNA. Gene amplification was done 
using HotStarTaq® MasterMix (Kit Qiagen, 
Venlo, The Netherlands). CpG-sites were identi-
fied manually in the 600bp promoter region of the 
mouse Cyp2a5 gene (ENSMUSG00000005547), 
and assessment of DNA methylation levels was 
performed on the PyroMarkQ24 (Qiagen) instru-
ment. Relative levels of methylation at each CpG- 
site were analysed with PyroMark Q24 2.0.6 soft-
ware. The amplification and sequencing primers 
used in this study are listed in Supplementary 
Table 1.
Microsomal membrane preparation
Microsomal membranes were obtained from 
homogenized livers of embryonic, neonatal, and 
adult mice for nicotine functional assay, as pre-
viously described [1,69]. Briefly, the homogenized 
liver tissue was centrifuged at 9000 g for 20 min-
utes at 4°C in phosphate buffer with EDTA. The 
supernatant fractions were collected and centri-
fuged at 100,000 g for 90 minutes at 4°C. The 
resultant pellets (microsomes) were collected and 
resuspended in phosphate buffer without EDTA. 
The collected supernatants (cytosolic fractions) 
were pooled for further use as source of aldehyde 
oxidase reaction in nicotine functional analysis. 
The content of microsomal protein was deter-
mined in each sample with an RC DC protein 
assay (BIO-rad kit RC DC protein Assay).
In vitro assay for nicotine metabolism
The metabolism of nicotine follows two steps, the 
first of which is the conversion of nicotine to 
nicotine- Δ1ʹ(5ʹ)-iminium ion by Cyp2a5 in the 
liver. Thereafter, the nicotine- Δ1ʹ(5ʹ)-iminium ion 
is converted to cotinine by aldehyde oxidase, 
which is present in cytosolic fraction. The liver 
microsomal protein was incubated with the pooled 
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cytosolic fraction and nicotine-containing solu-
tion. To ensure that the nicotine conversion was 
linear with time, and aldehyde oxidase availability 
was not rate-limiting, 45 minutes with incubation 
time (optimization: 15, 30, 45, and 60 min) and 
1 mg/ml with concentration of cytosolic protein 
(optimization: 0.25, 0.5, 1, 2, 3, 4, 6, 8 and 10 mg/ 
ml) [69] were used, as shown in Figure 4(a,b). 
Briefly, a normalized 0.5 mg/ml liver microsomal 
protein and 80 µl cytosolic fraction with a protein 
content of 1.0 mg/ml were added to a freshly pre-
pared nicotine-containing solution 80 µl, which is 
a mix of 4.4 µl S(-)-nicotine (≥99%, N3876, Sigma- 
Aldrich, St.Louis, MO), 1.5 ml demineralized 
water and 28.5 ml of 100 mM sodium phosphate 
buffer pH 7.4. The mixture was supplemented with 
phosphate buffer (pH 7.4) to a total volume of 
220 µl. After preheating this mixture at 37°C for 
5 minutes, 180 µl of freshly prepared NADPH in 
phosphate buffer containing 12.3 mM magnesium 
chloride (Sigma-Aldrich, St.Louis, MO), 55.8 mM 
potassium chloride, 1.17 mM D-Glucose-6-phos-
phate (≥98%, G7250, Sigma-Aldrich, St.Louis, 
MO) and 5.2 µl glucose-6-phosphate dehydrogen-
ase (Roche, Germany; Grade II from yeast) were 
added to the mixture for supplying the energy to 
recycle the CYP’s active site after oxidation. This 
mixture (400 µl in total) was incubated at 37°C for 
45 minutes in an incubator for the actual 
biotransformation.
Analysis for HPLC and LCMS
For the analysis of the biotransformation products 
of nicotine metabolism, the samples were prepared 
as previously described by E.S. Messina et al. [1] 
and H. Raunio et al. [2]. Briefly, the samples were 
alkalized by adding 20 µl of 10 M sodium hydro-
xide and mixing for 2–3 seconds on a vortex, to 
stop the reaction after the biotransformation assay, 
and to deprotonate the analytes. From this, the 
uncharged analytes were extracted in a two-step 
extraction. Each extraction step consisted of add-
ing 1 ml of dichloromethane, mixing thoroughly 
for 60 seconds on a vortex, spinning for 3 minutes 
at 10,000 g to separate the layers, after which the 
organic (lower) phase was collected. 20 µl of 2.5 M 
hydrochloric acid was added to the combined 
dichloromethane fractions, as suggested by A.M. 
Massadeh et al. [70]. Before evaporating the sol-
vent under a nitrogen atmosphere overnight at 
room temperature until dryness. Dried samples 
were reconstituted in 100 µl of HPLC buffer, 
which is a mix of 15% acetonitrile and 85% of 
20 mM phosphate buffer, pH 3.0, containing 
1,0 g/L heptane sulphonate sodium salt acid. The 
sample was analysed by reverse phase HPLC with 
UV detection (245 nm), as shown in Figure 4(c). 
The separation was performed on HPLC-L, 
a Hitachi system consisting of a L2130 pump (set 
at isocratic elution of 0,6 ml/min) and a L2300 
column oven set at 25°C. To confirm the identity 
of the peak in the chromatogram a fragment of the 
cotinine fraction from HPLC system was sent to 
Interfaculty Mass Spectrometry Centre (IMSC) at 
the University of Groningen. The sample was 
dried again under a nitrogen atmosphere and 
reconstituted in eluent (water and acetonitrile 
both containing formic acid) for the liquid chro-
matography separation. The sample was injected 
into LCMS system, which was measured in posi-
tive mode from m/z 100–1000 and parallel reac-
tion monitoring was included in the analysis for 
targeted analysis of the compounds with m/z 177. 
We identified that cotinine of the nicotine meta-
bolism experiment displayed the same retention 
time as the cotinine standard. In the LCMS analy-
sis, both the cotinine standard and the cotinine of 
the metabolism experiment were detected at an m/ 
z of 177.10 (Figure 4(d)).
Calculations and statistical methods
For statistical evaluation of the different groups, 
two-tailed Mann–Whitney U-test and Spearman’s 
correlation test were used (GraphPad Prism 7.02 
Software, San Diageo, CA and SPSS Statistics 23, 
IBM, The Netherlands). Comparisons of the 
methylation data among three different time 
points were conducted using one-way Analysis of 
Variance (ANOVA). P values were adjusted by the 
Bonferroni method. P ≤ 0.05 was considered sig-
nificant. Relative gene expression (2−ΔCt method) 
as well as mean percent methylation and standard 
error of the mean (SEM) were calculated in 
Microsoft® Office Excel 2003.
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